Perry Maxwell

2.2k total citations
63 papers, 1.6k citations indexed

About

Perry Maxwell is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Perry Maxwell has authored 63 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 21 papers in Molecular Biology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Perry Maxwell's work include Cancer Genomics and Diagnostics (12 papers), AI in cancer detection (10 papers) and Radiomics and Machine Learning in Medical Imaging (8 papers). Perry Maxwell is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), AI in cancer detection (10 papers) and Radiomics and Machine Learning in Medical Imaging (8 papers). Perry Maxwell collaborates with scholars based in United Kingdom, Canada and Ireland. Perry Maxwell's co-authors include Manuel Salto‐Tellez, Peter Hamilton, Jacqueline A. James, Matthew P. Humphries, Peter W. Hamilton, Stephen McQuaid, Joe M. O’Sullivan, David Waugh, Patrick G. Johnston and Darragh G. McArt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Perry Maxwell

61 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Perry Maxwell United Kingdom 24 676 530 360 335 223 63 1.6k
Katherine Moxley United States 26 515 0.8× 611 1.2× 375 1.0× 202 0.6× 107 0.5× 71 2.0k
Ivar Skaland Norway 23 467 0.7× 528 1.0× 565 1.6× 142 0.4× 220 1.0× 66 1.5k
Torill Sauer Norway 25 851 1.3× 529 1.0× 603 1.7× 370 1.1× 317 1.4× 108 2.1k
Heather Dawson Switzerland 28 1.3k 1.9× 400 0.8× 264 0.7× 337 1.0× 453 2.0× 99 2.1k
Susan Fineberg United States 22 636 0.9× 454 0.9× 494 1.4× 210 0.6× 302 1.4× 61 1.6k
Hirokazu Taniguchi Japan 23 697 1.0× 596 1.1× 225 0.6× 382 1.1× 136 0.6× 109 1.6k
Yu Sun China 20 553 0.8× 456 0.9× 311 0.9× 380 1.1× 118 0.5× 93 1.5k
Emiel A. M. Janssen Norway 24 576 0.9× 523 1.0× 488 1.4× 133 0.4× 370 1.7× 59 1.7k
Moritz Jesinghaus Germany 25 1.1k 1.7× 395 0.7× 351 1.0× 409 1.2× 220 1.0× 92 2.0k
Jan P. A. Baak Netherlands 29 782 1.2× 851 1.6× 680 1.9× 316 0.9× 455 2.0× 70 2.5k

Countries citing papers authored by Perry Maxwell

Since Specialization
Citations

This map shows the geographic impact of Perry Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry Maxwell more than expected).

Fields of papers citing papers by Perry Maxwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perry Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry Maxwell. The network helps show where Perry Maxwell may publish in the future.

Co-authorship network of co-authors of Perry Maxwell

This figure shows the co-authorship network connecting the top 25 collaborators of Perry Maxwell. A scholar is included among the top collaborators of Perry Maxwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perry Maxwell. Perry Maxwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Reilly, Paul G., et al.. (2023). Translation of tissue-based artificial intelligence into clinical practice: from discovery to adoption. Oncogene. 42(48). 3545–3555. 17 indexed citations
2.
Salto‐Tellez, Manuel, Perry Maxwell, & Peter Hamilton. (2018). Artificial intelligence—the third revolution in pathology. Histopathology. 74(3). 372–376. 108 indexed citations
3.
Humphries, Matthew P., Stephen McQuaid, Stephanie G. Craig, et al.. (2018). Critical Appraisal of Programmed Death Ligand 1 Reflex Diagnostic Testing: Current Standards and Future Opportunities. Journal of Thoracic Oncology. 14(1). 45–53. 47 indexed citations
4.
Maxwell, Perry, Melissa J. LaBonte, Chee Wee Ong, et al.. (2017). Treatment-induced hypoxia attenuates enzalutamide response and promotes resistance in pre-clinical models of prostate cancer. Annals of Oncology. 28. v8–v9.
5.
Hynes, Seán O., Brendan Pang, Jacqueline A. James, Perry Maxwell, & Manuel Salto‐Tellez. (2017). Tissue-based next generation sequencing: application in a universal healthcare system. British Journal of Cancer. 116(5). 553–560. 27 indexed citations
6.
Buckley, Niamh E., Claire Forde, Darragh G. McArt, et al.. (2016). Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment. Scientific Reports. 6(1). 23383–23383. 38 indexed citations
7.
8.
9.
McArt, Darragh G., Ken Mills, Mark Catherwood, et al.. (2013). Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis. PLoS ONE. 8(7). e69604–e69604. 85 indexed citations
10.
Mukhopadhyay, Asima, Elizabeth Ruth Plummer, Ahmed Elattar, et al.. (2012). Clinicopathological Features of Homologous Recombination–Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival. Cancer Research. 72(22). 5675–5682. 95 indexed citations
11.
Maxwell, Perry, et al.. (2011). External quality control for immunocytochemistry on cytology samples: a review of UK NEQAS ICC (cytology module) results. Cytopathology. 22(4). 230–237. 42 indexed citations
12.
Carser, Judith, Jennifer E. Quinn, Caroline O. Michie, et al.. (2011). BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer. Gynecologic Oncology. 123(3). 492–498. 52 indexed citations
13.
Watson, Jenny, Declan J. McKenna, Perry Maxwell, et al.. (2009). Hyperacetylation in prostate cancer induces cell cycle aberrations, chromatin reorganization and altered gene expression profiles. Journal of Cellular and Molecular Medicine. 14(6b). 1668–1682. 14 indexed citations
14.
Elliott, Karen L., Peter W. Hamilton, & Perry Maxwell. (2008). Fluorescence (FISH) and chromogenic (CISH) in situ hybridisation in prostate carcinoma cell lines: comparison and use of virtual microscopy. British Journal of Biomedical Science. 65(4). 167–171. 5 indexed citations
15.
Williamson, K, et al.. (2005). Phenotypic Changes in Mitochondrial Membrane Potential (Δψm) during Valinomycin‐Induced Depolarisation and Apoptosis. Analytical Cellular Pathology. 27(4). 231–236. 6 indexed citations
16.
Bielański, A., Susan A. Nadin‐Davis, C Simard, Perry Maxwell, & J. Algire. (2001). Experimental collection and transfer of embryos from bovine immunodeficiency virus (BIV) infected cattle. Theriogenology. 55(2). 641–648. 9 indexed citations
17.
Johnston, Simon D., R. G. P. Watson, Derek Middleton, et al.. (1999). Genetic, morphometric and immunohistochemical markers of latent coeliac disease. European Journal of Gastroenterology & Hepatology. 11(11). 1283–1288. 9 indexed citations
18.
Maxwell, Perry, Peter W. Hamilton, & James M. Sloan. (1996). THREE-DIMENSIONAL RECONSTRUCTION OF PERINEURAL INVASION IN CARCINOMA OF THE EXTRAHEPATIC BILE DUCTS. The Journal of Pathology. 180(2). 142–145. 11 indexed citations
19.
Maxwell, Perry, R. I. Davis, & James M. Sloan. (1993). Carcinoembryonic antigen (CEA) in benign and malignant epithelium of the gall bladder, extrahepatic bile ducts, and ampulla of vater. The Journal of Pathology. 170(1). 73–76. 18 indexed citations
20.
Heatley, M K, et al.. (1993). C-erbB-2 Oncogene Product Expression Depends on Tumour Type and is Related to Oestrogen Receptor and Lymph Node Status in Human Breast Carcinoma. Pathology - Research and Practice. 189(3). 261–266. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine Moxley Breakdown of academic impact, for papers by Ivar Skaland Breakdown of academic impact, for papers by Torill Sauer Breakdown of academic impact, for papers by Heather Dawson Breakdown of academic impact, for papers by Susan Fineberg Breakdown of academic impact, for papers by Hirokazu Taniguchi Breakdown of academic impact, for papers by Yu Sun Breakdown of academic impact, for papers by Emiel A. M. Janssen Breakdown of academic impact, for papers by Moritz Jesinghaus Breakdown of academic impact, for papers by Jan P. A. Baak
Rankless by CCL
2026